학술논문

Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum
Document Type
Article
Source
In: European Journal of Pharmaceutical Sciences. (European Journal of Pharmaceutical Sciences, 1 February 2022, 169)
Subject
Language
English
ISSN
18790720
09280987